Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion type Assertion NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_head.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion description "[KRAS mutations were frequent in villous (67%) and tubulovillous (60%) adenomas but were rare or absent in tubular adenomas (6%) and serrated lesions, including hyperplastic polyps, sessile serrated polyps/sessile serrated lesions and traditional serrated adenomas (0-9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_provenance.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion evidence source_evidence_literature NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_provenance.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion SIO_000772 22374786 NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_provenance.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion wasDerivedFrom befree-2016 NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_provenance.
- NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_assertion wasGeneratedBy ECO_0000203 NP964225.RARWmt4KWj4fnvuBIikGnQ4rzYB9x_ABSBXGykeEZvGb4130_provenance.